Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
US-2024199583-A1 · Jun 20, 2024 · US
US2016347758A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016347758-A1 |
| Application number | US-201615170677-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 1, 2016 |
| Priority date | Jun 1, 2015 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are compositions of tricarbazole triazolophane (tricarb) of Formulas (I), (II) and (III): wherein R of Formula (I) is selected from a group consisting of alkyl (for example, C 6 -C 18 ), alkyl-substituted phenyl derivatives, and substituted glycol derivatives, among others, or a combination thereof, and R , R ′ and R ″ of Formulas (II) and (III) are independently selected from a group consisting of alkyl (for example, C 6 to C 18 ), alkyl-substituted phenyl derivatives, and substituted glycol derivatives, or a combination thereof. The disclosure presents examples of thin films composed of the same as well as methods of binding anions from the same.
Opening claim text (preview).
The invention claimed is: 1 . A composition comprising a tricarbazole triazolophane (tricarb) selected from one of the following: or a combination thereof, wherein R of Formula (I) is selected from a group consisting of alkyl (for example, C 6 -C 18 ), alkyl-substituted phenyl derivatives, and substituted glycol derivatives, among others, or a combination thereof, and R , R ′ and R ″ of Formulas (II) and (III) are independently selected from a group consisting of alkyl (for example, C 6 -C 18 ), alkyl-substituted phenyl derivatives, and substituted glycol derivatives, among others, or a combination thereof. 2 . The composition of claim 1 , wherein R of Formula (I) is selected from a group consisting of C 6 H 13 (IA) C 10 H 21 (IB) C 18 H 37 (IC), di-tert-butyl phenyl (ID) and triethylene glycol (IE), or a combination thereof: 3 . The composition of claim 1 , wherein R is C 10 H 21 (IB): 4 . A complex, comprising: a composition of claim 1 , and an anion, wherein the composition binds the anion. 5 . The complex of claim 4 , wherein the anion is selected from a group consisting of I − , ClO 4 − , ReO 4 − , PF 6 − , SbF 6 − , FeCl 4 − , mesylate (CH 3 SO 3 − ), triflate (CF 3 SO 3 − ), arsenate (AsO 4 3− ), hexafluoroarsenate (AsF 6 − ), tetrachloroaluminate (AlCl 4 − ), phosphate (PO 4 3− ), hydrogenophosphate (HPO 4 2− ), dihydrogenophosphate (H 2 PO 4 − ), sulfate (SO 4 2− ), hydrogen sulfate (HSO 4 − ), tetracyanoborate (B(CN) 4 − ), a halide (Cl − , Br − , I − ), cyanide, perbromate (BrO 4 − ), periodate (IO 4 − ), fluoride (F − ), bifluoride (HF 2 − ), pertechnetate (TcO 4 − ), monosubstituted phosphate esters (RPO 4 2− ), disubstituted phosphate esters (R 2 PO 4 − ), organosulfonates (RSO 3 − ), thiocyanate, (SCN − ), azide (N 3 − ), triiodide (I 3 − ), carbonate (CO 3 2− ), monohydrogen carbonate (HCO 3 − ), iron tetrachlorate (FeCl 4 − ), gold dicyanate (Au(CN) 2 − ), acetate (CH 3 CO 2 − ), uranium hexafluoride (UF 6 − ), sulfide (S 2− ), platinum hexachlorate (PtCl 6 2− ), and S 2 2− , S 4 2− , S 6 2− , S 8 2− and S n 2− , where n is an even number, or a combination thereof, including mono- and poly-protonated forms (e.g., AsO 4 3− , HAsO 4 2− and H 2 AsO 4 − ), or a combination of the foregoing anions thereof. 6 . The complex of claim 4 , wherein a ratio of the composition comprising a tricarb to the anion in complexes formed therefrom is selected from 1:1 (tricarb:anion), 2:1 (tricarb:anion), 2:2 (tricarb:anion) and 3:2 (tricarb:anion), among others. 7 . The complex of claim 4 , wherein the anion displays one of a binding affinity parameter of log β 2 greater than 7 or a positive cooperativity greater than 5. 8 . A method of binding an anion, comprising: contacting the anion with a composition of claim 1 . 9 . A method of removing an anion from a mixture, comprising: contacting the mixture with a composition of claim 1 to form a complex comprising the anion and the composition; and separating the complex from the mixture. 10 . A thin film, comprising a composition of claim 1 . 11 . A method of binding an anion, comprising: contacting the anion with a thin film of claim 10 . 12 . A method of removing an anion from a mixture, comprising: contacting the mixture with a thin film comprising the composition of claim 1 to form a complex of the anion and the thin film or a dissociated dimer of a tricarb thereof, wherein the tricarb comprises the composition of claim 1 ; and separating from the mixture the complex of an anion and the thin film or the dissociated dimer of a tricarb thereof. 13 . A method of controlling the thickness of a thin film comprising the composition of claim 1 , wherein the thickness of the thin firm is determined is selected from the group consisting of one of the following parameters: varying a concentration of the composition of claim 1 , adding anions, and altering at least one substituent of the composition of claim 1 . 14 . The composition of claim 1 , wherein the tricarb can be oxidized. 15 . The complex of claim 6 , wherein the tricarb can be oxidized. 16 . A method of oxidation, comprising contacting the composition of claim 1 with an electrode to which is applied a positive voltage. 17 . A method of oxidation, comprising contacting the complex of claim 6 with an electrode to which is applied a positive voltage. 18 . A method of oxidation, comprising contacting the composition of claim 1 with an oxidizing agent. 19 . A method of oxidation, comprising contacting the complex of claim 6 with an oxidizing agent.
characterised by the use of ion-exchange material in the form of ribbons, filaments, fibres or sheets, e.g. membranes (electrodialysis or electro-osmosis B01D61/42) · CPC title
Halogens or halogen-containing compounds · CPC title
comprising organic material · CPC title
Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties (ion-exchange chromatography processes B01D15/36) · CPC title
by ion-exchange (ion-exchange in general B01J) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.